A multiple endpoint approach reveals potential in vitro anticancer properties of thymoquinone in human renal carcinoma cells
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 136, 111076
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UID/DTP/04138/2019, UID/DTP/04567/2019, PD/BD/114280/2016, TUBITAK/003/2014)
This publication has 71 references indexed in Scilit:
- Thymoquinone Inhibits Autophagy and Induces Cathepsin-Mediated, Caspase-Independent Cell Death in Glioblastoma CellsPLOS ONE, 2013
- Effect of Thymoquinone on Cytosolic pH and Na+/H+ Exchanger Activity in Mouse Dendritic CellsCellular Physiology and Biochemistry, 2012
- Upregulation of Chemoprotective Enzymes and Glutathione by Nigella sativa (Black Seed) and Thymoquinone in CCl4-Intoxicated RatsInternational Journal of Toxicology, 2011
- Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphomaFree Radical Biology and Medicine, 2011
- Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivoJournal of Experimental & Clinical Cancer Research, 2010
- Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic CancerCancer Research, 2009
- Oxidative injury in V79 Chinese hamster cells: protective role of the superoxide dismutase mimetic MnTM-4-PyPCell Biology and Toxicology, 2009
- Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathwaysMolecular Cancer Therapeutics, 2008
- The NCI60 human tumour cell line anticancer drug screenNature Reviews Cancer, 2006
- Immunosuppressive and cytotoxic properties of Nigella sativaPhytotherapy Research, 2004